Delivery Order SPE2DB20D1100-SPE2DB24FA3E2

Award Date 2/20/24
Potential Completion Date 3/12/24
Potential Value $9.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the provision of LENVIMA 14 MG DAILY DOSE 60S, a pharmaceutical product. The contract is a firm-fixed-price delivery order contract with a period of performance through March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LENVIMA 14 MG DAILY DOSE 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $9,910.95 and a period of performance through January 6, 2025. AmerisourceBergen Drug Corp is the prime contractor and there is no indication of any major subcontractors. The contract is not designated as a set-aside. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) Delivery Order, with an ultimate completion date of April 11, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $9,279.78 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the provision of LENVIMA 14 MG DAILY DOSE 60S. The contract has a completion date of March 4, 2024 and was awarded on February 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $9,910.95 contract is for the supply of LENVIMA 24 MG DAILY DOSE 90S, a pharmaceutical product. The contract has a period of performance through March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $9,279.78, is for the supply of the pharmaceutical product Lenvima 14 mg daily dose 60s. The award is associated with a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product LENVIMA 14 MG DAILY DOSE 60S. The contract has a potential value of $9,279.78 and a performance period through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. In addition to this delivery order,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $18,559.56, is for the supply of LENVIMA 8 MG DAILY DOSE 60S pharmaceutical product. Amerisourcebergen Drug Corp, through its Corporate Office division, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product LENVIMA 8 MG DAILY DOSE 60S. The contract has a ceiling value of $19,159.74 and is a firm fixed price agreement. The ultimate completion date is September 12, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the delivery of Lenvima 24 mg daily dose 90s, a specialty medication. The contract has a firm fixed price and an ultimate completion date of December 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA3E2
    Delivery Order

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of the pharmaceutical product LENVIMA 14 MG DAILY DOSE 60S, with a completion date of March 12, 2024 and a potential value of $9,279.78. Amerisourcebergen Drug Corp is the prime contractor and there are no known major subcontractors. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract does not have a set-aside designation.

Generated 5/21/24, 11:15 AM